Vifor Pharma AG GNHAF:OTCPK

RT Quote | Exchange | USD
Last | 02/08/21 EST
130.00UNCH (UNCH)
52 week range
106.18 - 163.00

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close130.00
  • 52 Week High163.00
  • 52 Week High Date03/11/20
  • 52 Week Low106.18
  • 52 Week Low Date03/17/20
  • Market Cap8,100.96M
  • Shares Out64.89M
  • 10 Day Average Volume-
  • Dividend2.07
  • Dividend Yield1.59%
  • Beta0.07
  • 1 Year % Change-25.74

RATIOS/PROFITABILITY

  • EPS (TTM)2.63
  • P/E (TTM)49.51
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date05/18/2020
  • Div Amount2.00
  • Split Date-
  • Split Factor-

Latest Vifor Pharma AG News

There is no recent news for this security.

Latest GNHAF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Vifor Pharma AG, formerly known as Galenica AG, is a Switzerland-based company engaged in the healthcare market. The Company operates through a single pharmaceutical segment. It develops, manufactures and markets pharmaceutical products, specializing in therapies for iron deficiency, nephrology and cardio-renal diseases. The Company's portfolio of iron deficiency treatments includes intravenous products, Ferinject and Venofer, and oral product, Maltofer, among others. Its...
Jacques Theurillat
Chairman
Romeo Cerutti
Vice Chairman
Stefan Schulze
Chief Executive Officer
Colin Bond
Chief Financial Officer
Gregory Oakes
Executive Vice President
Address
Rechenstrasse 37
St. Gallen
9014
Switzerland